EASIER DISCOVERIES WITH MICROFLUIDIC INSTRUMENT

“With the arrival of the microfluidic instrument ONYX, our custom single-cell workflows have taken a major leap forward in their sophistication, ease of deployment, and data quality.

The Droplet Genomics team has provided superb training and support as we have migrated to their open-ended systems and protocols. For both newcomers and veteran users of droplet methods, microfluidic company Droplet Genomics delivers an incredible product that we cannot recommend highly enough!"

"Orbit Discovery generates peptide libraries on the magnitude of millions or even billions of peptides but has been hindered by an ability to screen just 10,000 to 50,000 select peptides at a time using wells on plates. Our prime focus has been trying to identify new technologies that would allow us to smash through that barrier of limitation.

The STYX platform allowed us to make a quantum leap in terms of numbers and throughput. We can screen millions or even up to tens of millions of variants with this technology. There is not much else out there with similar capabilities. This has been a breakthrough technology product for us."

"Droplet Genomics has been instrumental in the launch of our custom microfluidics pipeline. Droplet Genomics provided excellent support and training to get us up-and-running quickly and helped refine our pipeline using their deep technical expertise. They are fun and easy to work with and consistently deliver a reliable product every time. Whether you are a newcomer or experienced user, Droplet Genomics is an incredible company to work with that I highly recommend!"

"Conducting large-scale atlasing projects on a DIY single-cell platform has presented us with a number of challenges, often more logistical than technical. Droplet Genomics has been instrumental to our research by supplying us with the tools we need to keep our projects moving forward during uncertain times. The quality and consistency of their devices gives us peace of mind and allows us to focus on the more pressing variables in our experiments. The products, services, and innovations they provide are an asset to the droplet microfluidics community."